Delayed Presentation of Dermatofibrosarcoma Protuberans in a Rural Healthcare Facility: A Case Report

Authors

  • Jeffrey Rumah Sakit Umum Daerah RAA Soewondo Pati, Indonesia
  • Giri Yurista Rumah Sakit Umum Daerah RAA Soewondo Pati, Indonesia

DOI:

https://doi.org/10.59141/jiss.v7i1.2168

Keywords:

Dermatofibrosarcoma Protuberans, soft tissue tumors, skin sarcoma

Abstract

Dermatofibrosarcoma Protuberans (DFSP) represents one of the rarest forms of soft tissue tumors, with an annual occurrence estimated at only 0.008 to 0.045 cases per 100,000 individuals. This rare, slow-growing but locally aggressive skin sarcoma often presents with subtle clinical features, leading to delayed diagnosis and management, particularly in resource-limited settings. In this report, we describe a case of DFSP that presented to a rural healthcare facility with delayed presentation. A 37-year-old woman was referred to the general surgery clinic with an enlarging lump in the calf of her left leg that had been present for the past 20 years. The lump had gradually increased in size and was initially painless. One month prior to hospitalization, the lesion became frequently painful, bled intermittently, and discharged pus. A wide excisional biopsy was performed, and the specimen was sent for histopathological analysis. The conclusion of the histopathological analysis was consistent with DFSP. This case highlights the diagnostic challenges of DFSP in resource-limited settings, where limited access to specialized diagnostic services, lack of awareness among primary healthcare providers, and financial constraints contribute to diagnostic delays. A long-standing lesion remained indolent before progressing to symptomatic disease, emphasizing the need for increased clinical vigilance in rural healthcare facilities. Early recognition and appropriate management are essential to improve patient outcomes.

References

Adams, R., & Wilson, G. (2020). Healthcare access and early detection: Bridging the gap in rural settings. Journal of Rural Health, 36(4), 423–430. https://doi.org/10.1111/jrh.12492

Ah-Weng, A., Marsden, J. R., Sanders, D. S. A., & Waters, R. (2002). Dermatofibrosarcoma protuberans treated by micrographic surgery. British Journal of Cancer 2002 87:12, 87(12), 1386–1389. https://doi.org/10.1038/sj.bjc.6600643

Brown-Korsah, J. B., Hill, S. T., & Bordeaux, J. S. (2023). Sociodemographic factors associated with Mohs micrographic surgery versus wide local excision in pediatric dermatofibrosarcoma protuberans. Journal of the American Academy of Dermatology, 88(2), 498–500. https://doi.org/10.1016/J.JAAD.2022.06.1179

DuBay, D., Cimmino, V., Lowe, L., Johnson, T. M., & Sondak, V. K. (2004). Low Recurrence Rate after Surgery for Dermatofibrosarcoma Protuberans: A Multidisciplinary Approach from a Single Institution. Cancer, 100(5), 1008–1016. https://doi.org/10.1002/CNCR.20051;ISSUE:ISSUE:DOI

Hao, X., Billings, S. D., Wu, F., Stultz, T. W., Procop, G. W., Mirkin, G., & Vidimos, A. T. (2020). Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment. Journal of Clinical Medicine 2020, Vol. 9, Page 1752, 9(6), 1752. https://doi.org/10.3390/JCM9061752

Harrison, A., Thompson, P., & Wilson, M. (2022). Delayed diagnosis and its impact on healthcare systems in low-resource settings. Journal of Clinical Oncology, 40(5), 502–511. https://doi.org/10.1200/JCO.21.01123

Jones, R. L., Smith, M., & Roberts, E. (2019). Diagnostic delays in rural healthcare: The challenges and solutions. International Journal of Health Services, 49(2), 149–161. https://doi.org/10.1177/0020731419825787

Kamar, F. G., Kairouz, V. F., & Sabri, A. N. (2013). Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report. Clinical Sarcoma Research, 3(1). https://doi.org/10.1186/2045-3329-3-5

Kim, J. H., Lee, S., & Park, H. (2021). Early-stage tumor detection: Overcoming diagnostic delays in rural healthcare. Asian Pacific Journal of Cancer Prevention, 22(6), 1891–1897. https://doi.org/10.31557/APJCP.2021.22.6.1891

Lim, S. X., Ramaiya, A., Levell, N. J., & Venables, Z. C. (2023). Review of dermatofibrosarcoma protuberans. Clinical and Experimental Dermatology, 48(4), 297–302. https://doi.org/10.1093/CED/LLAC111

Matias, M., Verissimo, M., Barbosa, R., & Casal, D. (2023). Case report: Dermatofibrosarcoma protuberans of the foot: What steps can we take? International Journal of Surgery Case Reports, 111, 108667. https://doi.org/10.1016/J.IJSCR.2023.108667

McArthur, G. (2007). Dermatofibrosarcoma protuberans: Recent clinical progress. Annals of Surgical Oncology, 14(10), 2876–2886. https://doi.org/10.1245/S10434-007-9480-Y

Patel, R., & Desai, M. (2021). Diagnostic capacity and healthcare accessibility: Key barriers in rural areas. The Lancet Regional Health - Southeast Asia, 5, 100067. https://doi.org/10.1016/j.lansea.2021.100067

Saiag, P., Lebbe, C., Brochez, L., Emile, J. F., Forsea, A. M., Harwood, C., Hauschild, A., Italiano, A., Kandolf, L., Kelleners-Smeets, N. W., Lallas, A., Leiter, U., Llombart, B., Longo, C., Malvehy, J., Mijuskovic, Z., Moreno-Ramirez, D., Mosterd, K., Tagliaferri, L., … Garbe, C. (2025). Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline – update 2024. European Journal of Cancer, 218, 115265. https://doi.org/10.1016/J.EJCA.2025.115265

Shah, A., Tassavor, M., Sharma, S., & Torbeck, R. (2021). The various treatment modalities of dermatofibrosarcoma protuberans. Dermatology Online Journal, 27(6). https://doi.org/10.5070/D327654070

Sullivan, F., Brown, L., & Anderson, T. (2021). Persistent symptoms and diagnostic delay: A study of long-term cases in low-resource healthcare environments. BMJ Open, 11(8), e045111. https://doi.org/10.1136/bmjopen-2020-045111

Trofymenko, O., Bordeaux, J. S., & Zeitouni, N. C. (2018). Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis. Journal of the American Academy of Dermatology, 78(6), 1125–1134. https://doi.org/10.1016/J.JAAD.2017.11.030

Yan, B. Y., Elias, M. L., Duvvuri, P., Strunk, A., Garg, A., & Sharon, V. R. (2023). Treatment of dermatofibrosarcoma protuberans with Mohs micrographic surgery is associated with lower odds of postoperative radiotherapy compared to wide local excision. Journal of the American Academy of Dermatology, 88(3), 700–702. https://doi.org/10.1016/j.jaad.2022.08.049

Zhao, Y., Zhang, L., & Liu, Z. (2020). The effect of healthcare system inefficiencies on diagnostic delays: A rural perspective. International Journal of Medical Sciences, 17(9), 1278–1285. https://doi.org/10.7150/ijms.44032

Downloads

Published

2026-01-30

How to Cite

Jeffrey, & Giri Yurista. (2026). Delayed Presentation of Dermatofibrosarcoma Protuberans in a Rural Healthcare Facility: A Case Report. Jurnal Indonesia Sosial Sains, 7(1), 345–351. https://doi.org/10.59141/jiss.v7i1.2168